Triple-negative breast cancer patient reacts to Moon Shots Program

submitted by: mdanderson
http://cancermoonshots.org Bree Sandlin, 37-year-old mother of young twins, was diagnosed with triple-negative breast cancer in August 2012. Sandlin shares her reaction to the news that triple-negative breast cancer is among the initial cancers that will be addressed as part of MD Anderson's Moon Shots Program to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.

Young melanoma patient offers advice for treatment

submitted by: mdanderson

Brian Rose, a young adult malignant melanoma patient at MD Anderson, gives hope by sharing his experience with cancer. Rose suggests relating your cancer battle to personal accomplishments. In Rose's case, this is through his experience as a Marine and baseball coach. Rose also discusses how his melanoma was diagnosed and gives the advice of taking each day as a gift.

Young melanoma patient shares positive outlook on treatment

submitted by: mdanderson

Brian Rose, a young adult malignant melanoma patient at MD Anderson, does not advise studying your cancer's statistics. Rose says, "If you see your name in those statistics, go ahead and believe it. Until you see your name on one of those studies it really means nothing." It's important to be surrounded by a team of family, friends and physicians that share your focus and do not be afraid to reach out for help.

UT MD Anderson Cancer Center launches unprecedented Moon Shots Program to increase patient survival during the next decade

submitted by: mdanderson
Inspired by America’s drive a generation ago to put a man on the moon, MD Anderson’s Moon Shots Program is a highly-concentrated effort to rapidly and dramatically decrease suffering and death in several major cancers, including acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS); chronic lymphocytic leukemia (CLL); lung; melanoma; prostate and two cancers linked at the molecular level: triple-negative breast and ovarian. Focused teams are building on new technology and...

Prospective cohort studies of vitamin B6 intake and colorectal cancer incidence: modification by time?

submitted by: zhang
BACKGROUND: The relation between vitamin B-6 intake and colorectal cancer risk remains uncertain. OBJECTIVE: We prospectively evaluated whether a higher vitamin B-6 intake in the remote past is more strongly associated with a lower risk of colorectal cancer than an intake in the recent past in the Nurses' Health Study and the Health Professionals Follow-Up Study. DESIGN: We assessed vitamin B-6 intake every 4 y by using validated food-frequency questionnaires and followed 86,440...
Authors: Xuehong Zhang, Jung Eun Lee, Jing Ma, Youjin Je, Kana Wu, Walter C. Willett, Charles S. Fuchs, Edward L. Giovannucci

Cancer vaccine to prevent breast cancer recurrence

submitted by: mdanderson
Download from iTunes: http://itunes.apple.com/us/itunes-u/cancer-vaccine-to-prevent/id43184821... A peptide vaccine appears to reduce the risk of breast cancer recurrence in women with varying levels of HER2 expression, according to research presented at this year's Annual Meeting of the American Society of Clinical Oncology (ASCO). This vaccine educates the immune system to recognize HER2 as an invader. After years of false starts, immunotherapy is a burgeoning and promising field for...